José Ángel
Ruiz Ortega
Universidad Autónoma de Chile
Temuco, ChilePublicaciones en colaboración con investigadores/as de Universidad Autónoma de Chile (4)
2018
-
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x)
Molecular Neurobiology
-
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 201-212
-
Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 286-299
2017
-
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors
Molecular Neurobiology, Vol. 54, Núm. 10, pp. 7722-7735